Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart...

Попова Л. В., Кондратиева Т. Б., Аксенова М. Б., Хлевчук Т. В., Каневская М. З.
Кардиология
Т. 59, Вып. 5, С. 68-79
Опубликовано: 2019
Тип ресурса: Статья

DOI:10.18087/cardio.2019.5.2633

Аннотация:
Non-vitamin K antagonist oral anticoagulants (NOACs) - direct oral anticoagulants - are getting the ever-broadening use in clinical practice. However, many problems related to optimal use of NOACs in specific clinical situations remain unresolved. European Heart Rhythm Association in April 2018 issued the renovated recommendations on the use of NOACs in patients with atrial fibrillation. The authors of recommendations presented some specific clinical variants for which they formulated practical advices based on the evidence obtained in randomized clinical trials. They also outlined the indications for use of NOACs, formulated practical start-program and scheme of subsequent follow-up management of patients taking NOACs. Recommendations contain information on pharmacokinetics of NOACs and their interactions with other drugs, consideration of feasibility of NOACs use in patients with chronic renal insufficiency or advanced liver disease. Many other practical problems are covered as well.
Ключевые слова:
anticoagulant agent; atrial fibrillation; cerebrovascular accident; chronic kidney failure; human; oral drug administration; Administration, Oral; Anticoagulants; Atrial Fibrillation; Humans; Renal Insufficiency, Chronic; Stroke
Язык текста: Русский
ISSN: 0022-9040
Попова Л. В.
Кондратиева Т. Б.
Аксенова М. Б. Марианна Борисовна 1957-
Хлевчук Т. В. Татьяна Васильевна 1958-
Каневская М. З. Марина Зиновьевна 1946-
Popova L. V.
Kondratieva T. B.
Aksenova M. B. Marianna Borisovna 1957-
Khlevchuk T. V. Tat`yana Vasilyevna 1958-
Kanevskaya M. Z. Marina Zinovyevna 1946-
Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart Rhythm Association Practical Guide)
Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart...
Текст визуальный непосредственный
Кардиология
Общество специалистов по сердечной недостаточности
Т. 59, Вып. 5 С. 68-79
2019
Статья
anticoagulant agent atrial fibrillation cerebrovascular accident chronic kidney failure human oral drug administration Administration, Oral Anticoagulants Atrial Fibrillation Humans Renal Insufficiency, Chronic Stroke
Non-vitamin K antagonist oral anticoagulants (NOACs) - direct oral anticoagulants - are getting the ever-broadening use in clinical practice. However, many problems related to optimal use of NOACs in specific clinical situations remain unresolved. European Heart Rhythm Association in April 2018 issued the renovated recommendations on the use of NOACs in patients with atrial fibrillation. The authors of recommendations presented some specific clinical variants for which they formulated practical advices based on the evidence obtained in randomized clinical trials. They also outlined the indications for use of NOACs, formulated practical start-program and scheme of subsequent follow-up management of patients taking NOACs. Recommendations contain information on pharmacokinetics of NOACs and their interactions with other drugs, consideration of feasibility of NOACs use in patients with chronic renal insufficiency or advanced liver disease. Many other practical problems are covered as well.